rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
DISHMAN PHARMACEUTICALS and CHEMICALS LTD. - Outcome of Board Meeting
< Back
13 Aug 2014
Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2014, inter alia, has taken following decisions:&lt;br/&gt;&lt;br/&gt;1. Board approved the proposal by way of passing an enabling resolution for issue of shares to Qualified Institutional Investors (QIP) upto Rs.200 crores, subject to approval of members.&lt;br/&gt;&lt;br/&gt;2. Board has also approved, in principal issuance of shares upto 2.5% of Paid-up share capital of the Company to Employees under Employee Stock Option Scheme (ESOP), subject to the detailed scheme being presented to the Board for their approval, and also subject to approval by the members of the Company.&lt;br/&gt;&lt;br/&gt;3. Board has appointed Mr. Mark Griffiths, Global CEO as an Additional Director of the Company w.e.f. September 01, 2014.
View all announcements for DISHMAN PHARMACEUTICALS and CHEMICALS LTD. Source: BSE India